Pyrogen Testing Market Share and Growth Factors, Covid-19 Impact ,Analysis 2021–2025 | River Laboratories, Inc. (US) ,Lonza (Switzerland) & Merck KGaA (Germany)
The growing focus on customised medicine, increased R&D in the pharmaceutical and biotechnology industries, rising prevalence of chronic diseases, increased awareness of food safety, and rising incidence of infectious diseases and pandemics are all driving market expansion.
The global
pyrogen testing market is expected to grow at a CAGR of 12.7 percent from USD
927 million in 2020 to USD 1,689 million in 2025.
COVID-19 is
a newly identified novel coronavirus that causes an infectious sickness.
COVID-19, which was mostly unknown until the outbreak in Wuhan, China, in
December 2019, has gone from a regional issue to a global pandemic in just a
few weeks. Since the World Health Organization (WHO) proclaimed COVID-19 to be
a pandemic, a number of established pharmaceutical and biopharmaceutical
companies, as well as small startups, have stepped up to create medicines and
vaccines to combat the infection caused by the novel coronavirus. According to
the WHO, there are currently 70 vaccine candidates in development, with three
of them being studied in human trials. The economic and social costs of the
pandemic have spurred governments around the world to increase funding for
vaccine development, resulting in a rise in the use of pyrogen testing kits in
COVID-19 research.
Because of
the rising prevalence of major infectious diseases and epidemics, the demand
for pyrogen testing procedures has been steadily increasing over the last
decade. During the projection period, demand for pyrogen testing procedures
(used for endotoxin and microbial identification) is predicted to rise due to
an increase in the global incidence of infectious diseases.
The APAC
region is a highly profitable market for the life sciences industry. For
example, India has been taking substantial steps to promote itself as the
world's leading major biopharmaceutical innovation hub, including fostering
public-private partnerships (PPPs) in biopharmaceutical R&D projects. South
Korea is also working to establish itself as a worldwide biotech centre.
North
America, Europe, Asia Pacific, Latin America, and the Middle East and Africa
make up the global pyrogen testing market. North America held the highest
proportion of the worldwide pyrogen testing market in 2019. The high
investment on pharmaceutical and biopharmaceutical research, increasing
pharmaceutical drug pipelines, a growing number of drug approvals, and
increased consumer awareness about product safety are all contributing to the
North American pyrogen testing market's growth.
Charles
River Laboratories, Inc. (US) Lonza (Switzerland) Merck KGaA (Germany) Thermo
Fisher Scientific, Inc. (US)

Comments
Post a Comment